These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17467819)

  • 1. Major differences in gene expression in human coronary smooth muscle cells after nebivolol or metoprolol treatment.
    Wolf SC; Sauter G; Jobst J; Kempf VA; Risler T; Brehm BR
    Int J Cardiol; 2008 Mar; 125(1):4-10. PubMed ID: 17467819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nebivolol and metoprolol on inflammatory mediators in human coronary endothelial or smooth muscle cells. Effects on neointima formation after balloon denudation in carotid arteries of rats treated with nebivolol.
    Wolf SC; Sauter G; Preyer M; Poerner T; Kempf VA; Risler T; Brehm BR
    Cell Physiol Biochem; 2007; 19(1-4):129-36. PubMed ID: 17310107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEbivolol inhibition of coronary artery smooth muscle cell proliferation after percutaneous coronary artery intervention. Results of the NESCIO Study, a randomized, double blind trial.
    Michels R; Krasznai K; Mäkel W
    Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1264-9. PubMed ID: 22195358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells.
    Brehm BR; Wolf SC; Bertsch D; Klaussner M; Wesselborg S; Schüler S; Schulze-Osthoff K
    Cardiovasc Res; 2001 Feb; 49(2):430-9. PubMed ID: 11164853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
    J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-inflammatory effects of nebivolol in human coronary smooth muscle cells: clinical implications.
    Celik T; Iyisoy A; Kardesoglu E; Fici F
    Int J Cardiol; 2009 Apr; 133(3):415-6. PubMed ID: 18237789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprolol.
    Fang Y; Nicol L; Harouki N; Monteil C; Wecker D; Debunne M; Bauer F; Lallemand F; Richard V; Thuillez C; Mulder P
    J Mol Cell Cardiol; 2011 Aug; 51(2):168-76. PubMed ID: 21640121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension.
    Serg M; Kampus P; Kals J; Zagura M; Zilmer M; Zilmer K; Kullisaar T; Eha J
    Scand J Clin Lab Invest; 2012 Sep; 72(5):427-32. PubMed ID: 22708640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers of the third generation inhibit endothelin-1 liberation, mRNA production and proliferation of human coronary smooth muscle and endothelial cells.
    Brehm BR; Bertsch D; von Fallois J; Wolf SC
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S401-3. PubMed ID: 11078433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
    Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
    J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
    Celik T; Iyisoy A; Kursaklioglu H; Kardesoglu E; Kilic S; Turhan H; Yilmaz MI; Ozcan O; Yaman H; Isik E; Fici F
    J Hypertens; 2006 Mar; 24(3):591-6. PubMed ID: 16467663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum.
    Reidenbach C; Schwinger RH; Steinritz D; Kehe K; Thiermann H; Klotz T; Sommer F; Bloch W; Brixius K
    Life Sci; 2007 Jun; 80(26):2421-7. PubMed ID: 17512554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ENOS is not activated by nebivolol in human failing myocardium.
    Brixius K; Song Q; Malick A; Boelck B; Addicks K; Bloch W; Mehlhorn U; Schwinger RH
    Life Sci; 2006 Aug; 79(13):1234-41. PubMed ID: 16716362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
    J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells.
    Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
    J Cell Biochem; 2007 Apr; 100(6):1395-405. PubMed ID: 17115413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
    Brodde OE; Philipp T
    Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of monocyte chemoattractant protein-1 and c-fms/macrophage colony-stimulating factor receptor to coronary artery disease: analysis of human coronary atherectomy specimens].
    Iso Y; Suzuki H; Sato T; Shoji M; Shibata M; Hamazaki Y; Koba S; Sakai T; Murakami M; Geshi E; Katagiri T
    J Cardiol; 2003 Jul; 42(1):29-36. PubMed ID: 12892039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome.
    Ayers K; Byrne LM; DeMatteo A; Brown NJ
    Hypertension; 2012 Apr; 59(4):893-8. PubMed ID: 22353614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
    Ignarro LJ
    Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.